American International Group, Inc. Monte Rosa Therapeutics, Inc. Transaction History

American International Group, Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$4.26 - $8.46 $366 - $727	86 Added 0.57%	15,246 $107,000
Q4 2023 Feb 13, 2024	SELL	$2.5 - $5.93 $152 - $361	-61 Reduced 0.4%	15,160 $85,000
Q3 2023 Nov 13, 2023	BUY	$4.78 - $7.22 $2,585 - $3,906	541 Added 3.69%	15,221 $72,000
Q2 2023 Aug 04, 2023	BUY	$4.53 - $8.4 $1,472 - $2,730	325 Added 2.26%	14,680 $100,000
Q1 2023 May 12, 2023	BUY	$5.95 - $8.21 $1,695 - $2,339	285 Added 2.03%	14,355 $111,000
Q4 2022 Feb 10, 2023	BUY	$6.71 - $9.72 $3,073 - $4,451	458 Added 3.36%	14,070 $107,000
Q3 2022 Nov 14, 2022	BUY	$7.17 - $12.16 $1,376 - $2,334	192 Added 1.43%	13,612 $111,000
Q2 2022 Aug 12, 2022	SELL	$6.15 - $14.99 $5,670 - $13,820	-922 Reduced 6.43%	13,420 $130,000
Q1 2022 May 13, 2022	BUY	$10.36 - $20.41 $82,175 - $161,892	7,932 Added 123.74%	14,342 $201,000
Q4 2021 Feb 11, 2022	BUY	$16.28 - $27.15 $1,253 - $2,090	77 Added 1.22%	6,410 $131,000
Q3 2021 Nov 12, 2021	BUY	$18.59 - $42.21 $117,730 - $267,315	6,333 New	6,333 $141,000

43.9M

141K

31.2K

Ticker GLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,713,900
Market Cap $329M
Description
Monte Rosa Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins. It develops an oral molecular glue degrader for GSPT1, a translational termination factor and degron-containing prot...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.